Glaukos Corporation

US$224.41As of Sun 8 Nov 2026, 12:00 UTC
NYSE:GKOSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 20.94%
Div yield —
ROE (22.84%)
Medical Devices
Beta (5Y) 0.68
PE TTM —
TSR TTM 154.81%
Mkt cap US$13.28B
ROIC (12.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$281
25.03%
403.70%
Hold 7|7|6|4|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
3.84
3.78
3.74
3.83
4.52%
(1.06%)
0.03%
4.18%
Revenue$M
662.2
682.0
707.7
697.0
3.22%
0.29%
4.97%
6.52%
Peers (US$13.28B)
Cap (US$)
PE
12.58B
80.43x
10.16B
23.90x
13.08B
20.86x
Capital
TTM
5Y
10Y
Leveragex
0.276
0.048
0.027
EBIT/Intx
0.854
0.934
0.754
Own earn%
(66.46)
134.13
93.08
Sh yield%
32.85
41.66
41.58
Owners
Insiders/Inst%
3.88
53.83
Short interest%
4.61
SBC / revenue%
5.28
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
3–12
$1 testx
—
Incr. ROIC%
2